Pfaff, Elke <br/><br/>
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study.  [electronic resource] 

 -  Neuro-oncology  05 2018 
 - 826-837 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-5866 
<br/><br/><label>Standard No.: </label>10.1093/neuonc/nox216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Biomarkers, Tumor--genetics<br/>Brain Neoplasms--diagnosis<br/>DNA Methylation<br/>DNA Modification Methylases--genetics<br/>DNA Repair Enzymes--genetics<br/>Feasibility Studies<br/>Female<br/>Follow-Up Studies<br/>Gene Expression Regulation, Neoplastic<br/>Glioblastoma--diagnosis<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Promoter Regions, Genetic<br/>Tumor Suppressor Proteins--genetics<br/>Exome Sequencing<br/>Whole Genome Sequencing